The COVID booster currently available is based on the JN.1 subvariant. Nimbus is a direct descendant of JN.1 – as is another ...

A new UK study shows that vaccinating pregnant women against RSV has led to a staggering 72% drop in hospitalizations of ...

The risk for severe RSV-related outcomes was effectively reduced among children and infants who received nirsevimab in real-world clinical settings.

The United States could soon have another tool in the fight against respiratory syncytial virus, an illness that’s the No. 1 cause of hospitalization in infants.

Respiratory Syncytial Virus or RSV is one of the most common respiratory viruses circulating today. Often thought of as only being dangerous to babies and toddlers due to how often child-related ...

Respiratory syncytial virus (RSV) is a leading cause of severe respiratory illness and death among children worldwide, particularly in children younger than 6 months and in low-income and ...

The risk of respiratory syncytial virus, or RSV, is on the rise, along with that of other illnesses including the flu, stomach flu and COVID-19.

Several types of viruses could be the culprit: respiratory syncytial virus (RSV), influenza, parainfluenza viruses, metapneumovirus, rhinoviruses, coronaviruses, enteroviruses, and adenoviruses ...

Respiratory syncytial virus (RSV) is a major cause of respiratory infections, particularly in infants, children under 5 years, and older adults. Its rapid spread makes RSV a serious public health ...

Cases of flu and respiratory syncytial virus (RSV) are ticking up across the United States even as overall respiratory virus activity remains low.

RSV or Respiratory Syncytial Virus might have symptoms similar to a common cold, but it can cause serious respiratory illnesses. Know all about it to avoid the risk.